How Francisella tularensis invades red blood cells and its role in disease spread

The mechanism and role of erythrocyte invasion by Francisella tularensis

NIH-funded research West Liberty University · NIH-10730228

This study is looking at how the bacteria that cause tularemia get into red blood cells and what that means for how the disease spreads, which could help us find better ways to prevent and treat infections for people at risk.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionWest Liberty University NIH-funded
Lab location1 site (West Liberty, United States)
Project IDNIH-10730228 on NIH RePORTER

What this research studies

This research investigates how the bacterium Francisella tularensis, which causes the severe disease tularemia, invades red blood cells (erythrocytes) and the implications of this invasion for disease transmission. The study focuses on understanding the interactions between the bacteria and various cell types, particularly erythrocytes, which may help the bacteria survive in ticks, a key vector for spreading the disease. By exploring the mechanisms of erythrocyte invasion, the research aims to uncover new insights into the pathogenesis of tularemia and its transmission dynamics. This could lead to better strategies for preventing and treating infections caused by this highly infectious organism.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals who may be at risk for tularemia, particularly those with exposure to ticks or environments where the bacterium is prevalent.

Not a fit: Patients who are not at risk for tularemia or have no exposure to the bacterium are unlikely to benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved prevention and treatment strategies for tularemia, potentially reducing the incidence of this serious disease.

How similar studies have performed: While the specific focus on erythrocyte invasion by Francisella tularensis is novel, previous research has shown success in understanding bacterial interactions with host cells, indicating potential for impactful findings.

Where this research is happening

West Liberty, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Arbovirus InfectionsArboviral infectionsArthropod-Born Viral Infectionarthropod-borne infectionarthropodborne infection
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.